William C. Vass

6.2k total citations · 1 hit paper
65 papers, 5.2k citations indexed

About

William C. Vass is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, William C. Vass has authored 65 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 20 papers in Genetics and 14 papers in Cell Biology. Recurrent topics in William C. Vass's work include Virus-based gene therapy research (19 papers), Protein Kinase Regulation and GTPase Signaling (14 papers) and RNA Interference and Gene Delivery (9 papers). William C. Vass is often cited by papers focused on Virus-based gene therapy research (19 papers), Protein Kinase Regulation and GTPase Signaling (14 papers) and RNA Interference and Gene Delivery (9 papers). William C. Vass collaborates with scholars based in United States, Denmark and Malaysia. William C. Vass's co-authors include Douglas R. Lowy, Alex G. Papageorge, John T. Schiller, Thierry Velu, Jeffrey E. DeClue, Edward M. Scolnick, Laura Beguinot, Nancy Ratner, Xiaolan Qian and Berthe M. Willumsen and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

William C. Vass

65 papers receiving 4.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis

1992 482 citations Alex G. Papageorge, Jonathan A. Fletcher et al. Cell profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
William C. Vass	3.1k	1.2k	1.1k	912	827	65	5.2k
Yuji Yamanashi	3.5k 1.1×	1.2k 1.0×	575 0.5×	512 0.6×	817 1.0×	94	7.1k
Robin Clark	2.2k 0.7×	837 0.7×	576 0.5×	551 0.6×	586 0.7×	37	3.6k
Jay L. Hess	7.4k 2.4×	1.1k 1.0×	825 0.8×	988 1.1×	287 0.3×	120	9.9k
Steven R. Tronick	3.7k 1.2×	1.5k 1.2×	1.9k 1.8×	713 0.8×	415 0.5×	104	6.8k
Keith C. Robbins	5.1k 1.7×	1.8k 1.5×	1.5k 1.4×	312 0.3×	896 1.1×	94	8.1k
K Toyoshima	2.8k 0.9×	2.1k 1.7×	732 0.7×	302 0.3×	327 0.4×	87	4.8k
K. D. Zang	1.4k 0.5×	563 0.5×	662 0.6×	1.1k 1.2×	351 0.4×	144	3.7k
Ruth H. Palmer	3.1k 1.0×	1.3k 1.1×	312 0.3×	394 0.4×	899 1.1×	121	5.4k
John Groffen	6.3k 2.0×	2.1k 1.8×	1.6k 1.5×	329 0.4×	944 1.1×	195	13.0k
Manuel O. Dı́az	4.3k 1.4×	1.5k 1.3×	991 0.9×	308 0.3×	335 0.4×	108	7.4k

Countries citing papers authored by William C. Vass

Since Specialization

Citations

This map shows the geographic impact of William C. Vass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. Vass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. Vass more than expected).

Fields of papers citing papers by William C. Vass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William C. Vass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. Vass. The network helps show where William C. Vass may publish in the future.

Co-authorship network of co-authors of William C. Vass

This figure shows the co-authorship network connecting the top 25 collaborators of William C. Vass. A scholar is included among the top collaborators of William C. Vass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. Vass. William C. Vass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qian, Xiaolan, Marian E. Durkin, Dunrui Wang, et al.. (2012). Inactivation of the Dlc1 Gene Cooperates with Downregulation of p15INK4b and p16Ink4a , Leading to Neoplastic Transformation and Poor Prognosis in Human Cancer. Cancer Research. 72(22). 5900–5911. 25 indexed citations

Du, Xiaoli, Xiaolan Qian, Alex G. Papageorge, et al.. (2012). Functional Interaction of Tumor Suppressor DLC1 and Caveolin-1 in Cancer Cells. Cancer Research. 72(17). 4405–4416. 42 indexed citations

Asnaghi, Laura, William C. Vass, Rafael Quadri, et al.. (2010). E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases. Oncogene. 29(19). 2760–2771. 61 indexed citations

Qian, Xiaolan, Guorong Li, William C. Vass, et al.. (2009). The Tensin-3 Protein, Including its SH2 Domain, Is Phosphorylated by Src and Contributes to Tumorigenesis and Metastasis. Cancer Cell. 16(3). 246–258. 75 indexed citations

Ha, Vi Luan, Hiroki Inoue, William C. Vass, et al.. (2008). ASAP3 Is a Focal Adhesion-associated Arf GAP That Functions in Cell Migration and Invasion. Journal of Biological Chemistry. 283(22). 14915–14926. 52 indexed citations

Lowy, Douglas R., Jeffrey E. DeClue, Ke Zhang, et al.. (2007). Cell Transformation by ras and Regulation of its Protein Product. Novartis Foundation symposium. 176. 67–84. 1 indexed citations

Li, Shaowei, Richard Braverman, Hongzhen Li, et al.. (2003). Regulation of cell morphology and adhesion by the tuberous sclerosis complex (TSC1/2) gene products in human kidney epithelial cells through increased E‐cadherin/β‐catenin activity. Molecular Carcinogenesis. 37(2). 98–109. 9 indexed citations

Nie, Zhongzhen, Markus Boehm, Emily S. Boja, et al.. (2003). Specific Regulation of the Adaptor Protein Complex AP-3 by the Arf GAP AGAP1. Developmental Cell. 5(3). 513–521. 71 indexed citations

Pastrana, Diana V., et al.. (2001). NHPV16 VLP Vaccine Induces Human Antibodies That Neutralize Divergent Variants of HPV16. Virology. 279(1). 361–369. 92 indexed citations

10.

Heffelfinger, Sue C., Giovanna Benvenuto, Bo Ling, et al.. (2000). Epidermal growth factor receptor expression in neurofibromatosis type 1–related tumors and NF1 animal models. Journal of Clinical Investigation. 105(9). 1233–1241. 141 indexed citations

11.

Qian, Xiaolan, Luis Miguel Pedrero Esteban, William C. Vass, et al.. (2000). The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties. The EMBO Journal. 19(4). 642–654. 89 indexed citations

12.

Miloso, Mariarosaria, Maria Carla Mazzotti, William C. Vass, & Laura Beguinot. (1995). SHC and GRB-2 Are Constitutively Activated by an Epidermal Growth Factor Receptor with a Point Mutation in the Transmembrane Domain. Journal of Biological Chemistry. 270(33). 19557–19562. 38 indexed citations

13.

DeClue, Jeffrey E., et al.. (1994). Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Molecular and Cellular Biology. 14(1). 641–645. 7 indexed citations

14.

Papageorge, Alex G., et al.. (1993). Regulated and Constitutive Activity by CDC25 ^Mm (GRF), a Ras-Specific Exchange Factor. Molecular and Cellular Biology. 13(12). 7718–7724. 45 indexed citations

15.

Papageorge, Alex G., Jonathan A. Fletcher, Scott R. Diehl, et al.. (1992). Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell. 69(2). 265–273. 482 indexed citations breakdown →

16.

Willumsen, Berthe M., William C. Vass, Thierry Velu, et al.. (1991). The Bovine Papillomavirus E5 Oncogene Can Cooperate with ras: Identification of p21 Amino Acids Critical for Transformation by c-ras ^H but Not v-ras ^H. Molecular and Cellular Biology. 11(12). 6026–6033. 19 indexed citations

17.

Zhang, Ke, Jeffrey E. DeClue, William C. Vass, et al.. (1990). Suppression of c-ras transformation by GTPase-activating protein. Nature. 346(6286). 754–756. 141 indexed citations

18.

Velu, Thierry, Laura Beguinot, William C. Vass, et al.. (1989). Retroviruses expressing different levels of the normal epidermal growth factor receptor: Biological properties and new bioassay. Journal of Cellular Biochemistry. 39(2). 153–166. 53 indexed citations

19.

Stone, James C., William C. Vass, Berthe M. Willumsen, & Douglas R. Lowy. (1988). p21- ras Effector Domain Mutants Constructed by "Cassette" Mutagenesis. Molecular and Cellular Biology. 8(8). 3565–3569. 3 indexed citations

20.

Lorek, Kenneth S., et al.. (1981). "Time-series properties of annual earnings data: The state of the art". 97–113. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact